Cargando…
Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice
Micro-dystrophin (μDys) gene therapeutics can improve striated muscle structure and function in different animal models of Duchenne muscular dystrophy. Most studies, however, used young mdx mice that lack a pronounced dystrophic phenotype, short treatment periods, and limited muscle function tests....
Autores principales: | Rodgers, Buel D., Bishaw, Yemeserach, Kagel, Denali, Ramos, Julian N., Maricelli, Joseph W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939027/ https://www.ncbi.nlm.nih.gov/pubmed/31909085 http://dx.doi.org/10.1016/j.omtm.2019.11.015 |
Ejemplares similares
-
Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in mdx Mice
por: Moore, Timothy M., et al.
Publicado: (2020) -
Sildenafil ameliorates cardiomyopathy in dystrophin-null (mdx) mice
por: Parchen, Candace M, et al.
Publicado: (2009) -
Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice
por: Rauch, Uwe, et al.
Publicado: (2012) -
Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice
por: Gao, Xianjun, et al.
Publicado: (2015) -
Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-Deficient mdx Mice
por: Gao, Xianjun, et al.
Publicado: (2020)